Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

Recruiting now · Not applicable

Conditions studied: Conduction System Pacing, Conventional Ventricular Pacing

In brief

The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.

Key facts

Study ID

NCT05214365

Run by

Hospital Clinic of Barcelona

People needed

200

Starts

2022-02-01

Expected to finish

2026-09-01

Last updated by the study team

2026-03-31

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient must be ≥ 18 years of age.
• The patient must indicate their acceptance to participate in the study by signing an informed consent document.
• Patients with EF> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines.

You may not qualify if…

• Inability to understand and sign the informed consent.
• Patients with severe comorbidities and life expectancy <1 year.
• Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life.
• Patients who cannot come to our center to carry out the follow-up of the study.

Where it is running

• Hospital Clinic of Barcelona — Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.